Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Rilpivirine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Edurant 25mg tablets
0503010AGBBAAAA
|
Edurant | Rilpivirine | Infections | No data available |
|
Rekambys 900mg/3ml prolonged-release inj vials
0503010AGBCAAAB
|
Rekambys | Rilpivirine | Infections | No data available |
|
Rilpivirine 25mg tablets
0503010AGAAAAAA
|
Rilpivirine | Rilpivirine | Infections | No data available |
|
Rilpivirine 900mg/3ml prolonged-release inj vials
0503010AGAAABAB
|
Rilpivirine | Rilpivirine | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.